Why sexual health clinics are important in the 2020s.


Journal

Sexual health
ISSN: 1449-8987
Titre abrégé: Sex Health
Pays: Australia
ID NLM: 101242667

Informations de publication

Date de publication:
08 2022
Historique:
received: 13 05 2022
accepted: 14 07 2022
pubmed: 4 8 2022
medline: 1 9 2022
entrez: 3 8 2022
Statut: ppublish

Résumé

To make services more accessible, acceptable and affordable, sexual health service delivery models have embraced innovation, technology, outreach and decentralisation. In particular, some routine high-volume services, like asymptomatic testing for sexually transmitted infections (STIs), can be delivered in general practice, online or in non-clinical settings. On the surface, sexual health clinics, like hospitals or other primary care clinics, might appear to be operating on a model that has not changed significantly in recent times. However, globally sexual healthcare needs are rising both in volume and complexity, not all of which can be adequately met through decentralised care. Sexual health clinics themselves are the site of considerable innovation. The importance of sexual health clinics in the diagnosis and treatment of symptomatic STIs is likely to increase with the increasing burden of disease, the complexity of treatment guidelines and the emergence of new infections. Services essential to patient health such as immediate or complex clinical care, partner notification and safeguarding, and activities essential to the health system like research, training and supervision require expertise to be located where it can be accessed and maintained at reasonable cost. We do not know whether increasing some services outside existing models can safely compensate for reducing other services inside them.

Identifiants

pubmed: 35922116
pii: SH22078
doi: 10.1071/SH22078
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

329-335

Auteurs

Nicholas A Medland (NA)

Kirby Institute, UNSW Sydney, Sydney, NSW, Australia; and Nottingham University Hospitals NHS Trust, Nottingham, UK.

Ruth Taylor (R)

Nottingham University Hospitals NHS Trust, Nottingham, UK.

John Saunders (J)

Blood Safety, STIs and HIV Division, UK Health Security Agency, London, UK; and Institute for Global Health, University College London, London, UK.

Michael Rayment (M)

Chelsea and Westminster Hospital, NHS Foundation Trust, London, UK.

Ashini Fox (A)

Nottingham University Hospitals NHS Trust, Nottingham, UK.

Ann Sullivan (A)

Blood Safety, STIs and HIV Division, UK Health Security Agency, London, UK; and Chelsea and Westminster Hospital, NHS Foundation Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH